KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.94 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $15,007,000 | +14.1% | 10,874,613 | 0.0% | 0.33% | +40.9% |
| Q4 2021 | $13,158,000 | -53.8% | 10,874,613 | 0.0% | 0.23% | -41.3% |
| Q3 2021 | $28,491,000 | -50.6% | 10,874,613 | 0.0% | 0.40% | -57.3% |
| Q2 2021 | $57,635,000 | -21.4% | 10,874,613 | 0.0% | 0.92% | -16.3% |
| Q1 2021 | $73,295,000 | -0.6% | 10,874,613 | 0.0% | 1.10% | +7.2% |
| Q4 2020 | $73,730,000 | -9.6% | 10,874,613 | 0.0% | 1.03% | -30.9% |
| Q3 2020 | $81,560,000 | -28.6% | 10,874,613 | 0.0% | 1.49% | -33.0% |
| Q2 2020 | $114,292,000 | +19.6% | 10,874,613 | 0.0% | 2.23% | -26.2% |
| Q1 2020 | $95,588,000 | +470.9% | 10,874,613 | +139.7% | 3.02% | +494.3% |
| Q4 2019 | $16,743,000 | -3.0% | 4,537,478 | 0.0% | 0.51% | -50.6% |
| Q3 2019 | $17,265,000 | -40.4% | 4,537,478 | 0.0% | 1.03% | -33.8% |
| Q2 2019 | $28,949,000 | -22.9% | 4,537,478 | 0.0% | 1.55% | -4.0% |
| Q1 2019 | $37,525,000 | +69.1% | 4,537,478 | 0.0% | 1.62% | +25.2% |
| Q4 2018 | $22,188,000 | +6.4% | 4,537,478 | +114.7% | 1.29% | +15.9% |
| Q3 2018 | $20,858,000 | -28.1% | 2,113,236 | 0.0% | 1.12% | -40.8% |
| Q2 2018 | $29,015,000 | -13.3% | 2,113,236 | 0.0% | 1.88% | -26.5% |
| Q1 2018 | $33,453,000 | -14.4% | 2,113,236 | 0.0% | 2.56% | -21.6% |
| Q4 2017 | $39,074,000 | -19.0% | 2,113,236 | 0.0% | 3.27% | -25.0% |
| Q3 2017 | $48,266,000 | – | 2,113,236 | – | 4.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,333,333 | $5,073,000 | 100.00% |
| CAXTON CORP | 1,483,343 | $5,644,000 | 6.36% |
| Polaris Venture Management Co. V, L.L.C. | 1,197,032 | $4,555,000 | 2.59% |
| RA Capital Management | 4,537,478 | $17,265,000 | 1.03% |
| Orbimed Advisors | 3,447,840 | $13,119,000 | 0.25% |
| Matisse Capital | 46,500 | $177,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 332,831 | $1,266,000 | 0.22% |
| Sofinnova Investments, Inc. | 478,206 | $1,819,000 | 0.16% |
| HARBOURVEST PARTNERS LLC | 99,186 | $377,000 | 0.16% |
| ALGERT GLOBAL LLC | 47,195 | $180,000 | 0.07% |